- CDK4/6i-Based Therapies in HR+ mBC: Optimizing Treatment Selection
- Post-Frontline CDK4/6: How do you sequence in Advanced/Metastatic Breast Cancer?
- Real World Oncology: Translating Data to Clinical Practice
- Reshaping HR+ Advanced or Metastatic Breast Cancer: Antibody-Drug Conjugates (ADC)
- Top Insights for TNBC and HER2+ Breast Cancer
- Live Q&A
OncLive® State of the Science Summit™ Breast Cancer
The Pierre, A Taj Hotel, New York
2 E 61st St
New York, NY 10065
Tuesday, January 13, 2026
6:00 PM-8:15 PM EST
Complimentary Parking
In-Person Only
Event Chair
Yelena Novik, MD
NYU Langone's Perlmutter Cancer Center
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831